Zobrazeno 1 - 10
of 221
pro vyhledávání: '"early T-cell precursor"'
Autor:
Jieping Lin, Zicong Huang, Zihong Cai, Jia Li, Zhen Li, Chenhao Ding, Zhixiang Wang, Xiaofang Li, Xuan Zhou, Bailin He, Wenhao Zhong, Li Xuan, Qifa Liu, Yang Xu, Hongsheng Zhou
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-5 (2024)
Abstract Early T-cell precursor lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) is a distinct subtype of T-ALL/LBL, characterized by a poor response to initial chemotherapy, a high relapse rate, and an inferior outcome. The treatment options for ETP-AL
Externí odkaz:
https://doaj.org/article/8af16b506c4b44ed9dfd1932f46c90d0
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 264-269 (2024)
Introduction: Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a rare subtype of T-cell leukemia that phenotypically expresses mature T-cell markers and immature myeloid markers such as CD33. Gemtuzumab ozogamicin (GO) is a novel agen
Externí odkaz:
https://doaj.org/article/e4a877c7ac114cfe989d3581610af225
Autor:
Yuxia Jiang, Lin Ji, Xin Jin, Haiying Wu, Mingxia He, Fenglin Shen, Xiaofeng Xu, Huifang Jiang
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a highly aggressive subtype of T-ALL. No standard chemotherapy regimen exists for patients with recurrent/refractory (R/R) ETP-ALL; in these patients, the primary goal of salvage therap
Externí odkaz:
https://doaj.org/article/ed9dd0b1ac154aa7a09a6fba3d6f18f6
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 35, Iss 1, Pp 1-12 (2023)
Abstract Background T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy with few accepted prognostic factors that limit the efficiency of therapy. The aim of the current study was to assess the clinical and laboratory features of
Externí odkaz:
https://doaj.org/article/9a5ec78ec6104c47a2a987874851219c
Autor:
Hamza Tariq, Sindhu Shetty
Publikováno v:
Turkish Journal of Hematology, Vol 40, Iss 3, Pp 227-229 (2023)
Externí odkaz:
https://doaj.org/article/138a9e4f0023451aae8a11d4ed6228ee
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2024)
The most frequent haematological malignancy associated with acquired hypo/dysfibrinogenemia is multiple myeloma. We present an unusual case of severe haemorrhagic diathesis due to acquired hypofibrinogenemia in a patient with early T-cell precursor a
Externí odkaz:
https://doaj.org/article/d3919bd51c1841b78ea0e57038374679
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hai-ping Dai, Wei Cui, Qing-ya Cui, Wen-juan Zhu, Hui-min Meng, Min-qing Zhu, Xia-ming Zhu, Lin Yang, De-pei Wu, Xiao-wen Tang
Publikováno v:
Biomarker Research, Vol 10, Iss 1, Pp 1-5 (2022)
Abstract Patients with relapsed/refractory early T-cell precursor lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) respond poorly to traditional therapy and have dismal prognosis. CD7 is a promising therapeutic targets for chimeric antigen receptor modi
Externí odkaz:
https://doaj.org/article/f738c74456a74142bdfdba9feeb94ca5
Publikováno v:
International Journal of General Medicine, Vol Volume 14, Pp 659-664 (2021)
Xiaoying Xu,1 Qiongli Zhai,1 Hao Jin,2 Yong Yu,3 Dongmei Han,2 Huilai Zhang,4 Kai Fu,5 Bin Meng1 1Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cance
Externí odkaz:
https://doaj.org/article/bbb938584f004022a02516c3face763a
Autor:
Jinyan Xiao, Zihong Cai, Hao Wang, Xuekai Li, Biqi Zhou, Yujie Liu, Ying Wang, Peipei Xu, Li Wang, Depei Wu, Liping Dou, Hongsheng Zhou, Yang Xu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Early T-cell precursor (ETP) lymphoblastic leukemia/lymphoma is a high-risk T lymphoblastic leukemia/lymphoma (T-ALL/LBL) subgroup. We performed a real-world multicenter study to explore the clinical characteristics and prognosis of adolescent and yo
Externí odkaz:
https://doaj.org/article/e48a75807e8e40ec9369e8c9b20a17d6